OPK
OPKO Health Inc
Price:  
1.40 
USD
Volume:  
1,222,753.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OPK EV/EBITDA

-93.0%
Upside

As of 2025-09-15, the EV/EBITDA ratio of OPKO Health Inc (OPK) is -15.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPK's latest enterprise value is 1,188.10 mil USD. OPK's TTM EBITDA according to its financial statements is -76.84 mil USD. Dividing these 2 quantities gives us the above OPK EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 11.4x - 16.8x 14.6x
Forward P/E multiples 14.6x - 17.0x 15.8x
Fair Price (1.20) - 1.86 0.10
Upside -186.0% - 32.5% -93.0%
1.40 USD
Stock Price
0.10 USD
Fair Price

OPK EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-12 -15.46
2025-09-11 -15.77
2025-09-10 -15.56
2025-09-09 -15.56
2025-09-08 -15.67
2025-09-05 -14.94
2025-09-04 -15.25
2025-09-03 -15.25
2025-09-02 -15.05
2025-08-29 -15.25
2025-08-28 -15.67
2025-08-27 -15.67
2025-08-26 -15.36
2025-08-25 -15.36
2025-08-22 -15.56
2025-08-21 -15.25
2025-08-20 -15.36
2025-08-19 -15.05
2025-08-18 -15.46
2025-08-15 -15.15
2025-08-14 -14.94
2025-08-13 -14.94
2025-08-12 -14.63
2025-08-11 -14.43
2025-08-08 -13.91
2025-08-07 -13.71
2025-08-06 -14.12
2025-08-05 -14.01
2025-08-04 -14.12
2025-08-01 -13.29
2025-07-31 -14.22
2025-07-30 -14.84
2025-07-29 -14.94
2025-07-28 -14.94
2025-07-25 -15.15
2025-07-24 -15.46
2025-07-23 -15.77
2025-07-22 -15.25
2025-07-21 -15.46
2025-07-18 -14.94
2025-07-17 -15.25
2025-07-16 -15.05
2025-07-15 -14.74
2025-07-14 -14.84
2025-07-11 -14.94
2025-07-10 -15.05
2025-07-09 -15.25
2025-07-08 -15.05
2025-07-07 -14.84
2025-07-03 -15.05